The Restorix Foundation is an independently run non-profit organization.
The Restorix Foundation raises funds to advance promising hyperbaric oxygen therapy through evidence-based research and education and supports compassionate care.
Restorix Foundation partners with organizations like the Restorix Research Institute on investigating innovative opportunities involving hyperbaric medicine and adjunctive therapies, expanding awareness of these minimally invasive techniques in the medical community and general public and providing philanthropic funds for the care of patients in need.
Contributions to our Foundation are directly invested in our non-profit programs.
What is Hyperbaric Oxygen Therapy?
A well-established treatment for decompression sickness—a hazard of scuba diving—hyperbaric oxygen therapy (HBOT) involves breathing pure oxygen in a pressurized room or chamber. Inside the chamber, the air pressure is increased up to three times higher than normal air pressure. As seen in the picture for this post, the patient lies comfortably in the chamber, and breathes pure oxygen. Under the increased pressure conditions, the lungs can gather up to three times more oxygen than breathing pure oxygen at regular air pressure.
HBOT works by speeding more oxygen to the body’s tissues, helping them to heal. According to the Mayo Clinic, when tissues are injured, they require even more oxygen to survive. HBOT increases the amount of oxygen the blood can carry, temporarily restoring normal levels of blood gases and tissue function to promote healing and fight infection.
HBOT is also used to treat serious infections, wounds that won’t heal (often as a result of diabetes), gangrene, crushing injuries, burns, skin grafts, carbon monoxide poisoning, and radiation injuries. Some practitioners recommend it for the treatment of allergies, arthritis, cancer, cerebral palsy, traumatic brain injuries, chronic fatigue syndrome, fibromyalgia, stroke, and gastrointestinal ulcers, but funding for more research is needed to determine the efficacy and FDA approval.